Note that some links may require subscriptions.
Germany is contemplating a €2,500 fine ($2,790) for parents who fail to provide proof their children are vaccinated against measles, and these children would be banned from daycare facilities. (AP)
FDA approves Pfizer’s drug tafamidis, to be sold in two formulations named Vyndaqel and Vyndamax, as the first agent specifically for cardiomyopathy associated with wild-type or hereditary transthyretin-mediated amyloidosis, the company said early Monday. Reuters reports that the drug will cost $225,000 per year.
New York City hospitals have tapped into a new resource in their fight to contain a measles outbreak: the electronic medical record. (Reuters)
An Ohio appellate court has ruled that the frozen embryos lost in a fertility clinic storage tank malfunction were not “living persons.” (CNN)
Johnson & Johnson is steeling itself for a live televised trial on allegations the company contributed to the state of Oklahoma’s opioid epidemic. (Washington Post)
On Friday the FDA expanded the indication of ado-trastuzumab emtansine (Kadcyla) in HER2-positive breast cancer to include the adjuvant treatment of residual disease post-surgery in patients who received neoadjuvant treatment, Genentech announced.
A midwife from Ethiopia tells NPR what inspired her to seek out the profession, and why midwives are so important.
The CBD market is rolling in the green (money, that is). (CBS News)
And as CNBC reports, even Fido has become a fan, with CBD products claimed to help with dogs’ pain and thunderstorm anxiety.
Even pediatricians aren’t perfect parents. One expert shares the five parenting mistakes that she makes as a doctor. (KevinMD)
And a Scientology measles cruise ship update: Authorities on the island of Curaçao have pinpointed one infected crew member, and have started vaccinating people on board to prevent infections. (NBC News)
Morning Break is a daily guide to what’s new and interesting on the Web for healthcare professionals, powered by the MedPage Today community. Got a tip? Send it to us: MPT_editorial@everydayhealthinc.com